CoChat

Quantification of tumor heterogeneity: from data acquisition to metric generation

Open access
Kashyap, Aditya, Rapsomaniki, Maria Anna, Barros, Vesna, Fomitcheva-Khartchenko, Anna, Martinelli, Adriano Luca, Rodriguez, Antonio Foncubierta, Gabrani, Maria, Rosen-Zvi, Michal, Kaigala, Govind · 2022 · Trends in Biotechnology
Cited by 98

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Tumors are unique and complex ecosystems, in which heterogeneous cell subpopulations with variable molecular profiles, aggressiveness, and proliferation potential coexist and interact.Understanding how heterogeneity influences tumor progression has important clinical implications for improving diagnosis, prognosis, and treatment response prediction.Several recent innovations in data acquisition methods and computational metrics have enabled the quantification of spatiotemporal heterogeneity across different scales of tumor organization.Here, we summarize the most promising efforts from a common experimental and computational perspective, discussing their advantages, shortcomings, and challenges.With personalized medicine entering a new era of unprecedented opportunities, our vision is that of future workflows integrating across modalities, scales, and dimensions to capture intricate aspects of the tumor ecosystem and to open new avenues for improved patient care. Tumor heterogeneity: scales, dimensions, and implicationsTissue architecture is organized functionally, with several cell subpopulations (see Glossary) contributing with distinct roles in maintaining homeostasis.At the onset of oncogenesis, tissue organization is disrupted by an uncontrolled splurge of genetically unstable cell subpopulations in a limited spatial niche.Increased genomic variability gradually translates to elevated phenotypic and functional variability, contributing to what is commonly referred to as tumor heterogeneity.As these heterogeneous subpopulations expand and interact with one another and their microenvironment, they generate cancer ecosystems, following evolutionary principles of traditional ecology [1].From the inner workings of a single cell to the patterns observed at a population level, heterogeneity is omnipresent across all scales of tumor organization.Stemming from intrinsic genetic instability and further amplified by other sources of variability at the epigenetic, transcriptional, or protein levels, tumor heterogeneity manifests in both a spatial and temporal dimension [2] (Figure 1).Temporal heterogeneity is present in the dynamic processes underlying cancer initiation, evolution, and metastasis [3].Spatial heterogeneity describes the complex tumor architecture, notably the interplay between cancer, immune, or stromal cells, and access to nutrients and growth factors through the vasculature or regional hypoxia [4].Moving up the scale of complexity, heterogeneity leads to spatiotemporal variability in tumor size, shape, texture, and organ localization, both within and across patients.Tumor heterogeneity has a substantial impact on treatment response and disease outcome [5,6].Given that cancer cells constantly evolve disease progression mechanisms or treatment escape routes [7], monitoring and quantifying tumor heterogeneity at diagnosis, during treatment, and possibly during disease resistance, is vital.To address this need, a plethora of data acquisition Highlights Understanding tumor complexity and applying that knowledge to advance patient care is a cornerstone of cancer research.However, tumor heterogeneity obfuscates this vision.Contemporary research contains a diverse set of technologies and computational tools for detecting, characterizing, and quantifying tumor heterogeneity at the molecular, architectural, organ, patient, or population level.Evaluation of the clinical relevance of heterogeneity metrics and creating actionable intelligence for the clinics, requires a common lexicon across disciplines, and a unified look toward multimodal data acquisition and computational analysis, the constraints they present, and how they partake in whole workflows.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibtech.2021.11.006

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 98

Metadata

Authors
Kashyap, A., Rapsomaniki, M. A., Barros, V., Fomitcheva-Khartchenko, A., Martinelli, A. L., Rodriguez, A. F., Gabrani, M., Rosen-Zvi, M., & Kaigala, G.
Venue
Trends in Biotechnology
Publisher
Elsevier BV
Published
2022-06
Volume
40
Issue
6
Pages
647-676
ISSN
0167-7799 (ISSN-L)
OpenAlex
W4200324152
Cited by
98
References
28
FWCI
1.40
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantification of tumor heterogeneity: from data acquisition to metric generation. https://app.cochat.ai/papers/10.1016/j.tibtech.2021.11.006
The paper
Kashyap, A., Rapsomaniki, M. A., Barros, V., Fomitcheva-Khartchenko, A., Martinelli, A. L., Rodriguez, A. F., Gabrani, M., Rosen-Zvi, M., & Kaigala, G. (2022). Quantification of tumor heterogeneity: from data acquisition to metric generation. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2021.11.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.